EPCAM and lung cancer: Several independent research teams have successively confirmed that the ZEB1‐driven EMT process in lung cancer cells was accompanied by a decrease in the expression of the epithelial cell adhesion molecule E‐cadherin and EPCAM and an increase in the expression of the cytoskeletal protein vimentin.14, 15, 16